cncpt-artikel_lb_atf
Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival
At the WCLC’s Presidential Symposium on Monday, September 11, 2023, Dr. Pasi A. Jänne will present new data from the clinical phase 3 study, FLAURA2.